Difficulty: Medium
Average Score: 94%
Practice
The client has MRSA and receives vancomycin (Vancocin) intravenously (IV). The nurse assesses an upper body rash and decreased urine output. What is the nurse's priority action?
Correct answer
A
Rationale
Vancomycin, a glycopeptide antibiotic, is critical for treating MRSA but carries risks of hypersensitivity reactions (e.g., rashes) and nephrotoxicity (e.g., reduced urine output). The nurse's priority when observing an upper body rash and decreased urine output is to hold the next dose and notify the physician . This action prevents further drug administration that could worsen a potential allergic reaction or kidney damage, both serious adverse effects requiring immediate medical evaluation. An X-ray might assess lung involvement in severe cases but isn't the first step for these symptoms. An antihistamine could treat mild itching but risks masking a systemic reaction, delaying critical care. A urine specimen might confirm renal issues but doesn't address the urgency of stopping the drug. Holding the dose ensures patient safety while awaiting physician guidance, aligning with nursing protocols for adverse drug reactions, making A the most prudent and timely action.